Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon
Contents
Chair
Massimo Colombo, MD
Chairman of EASL International Liver Foundation in Geneva, Switzerland;
Director of the Liver Center and General Medicine 8 at San Raffaele Hospital, Milan, Italy. (2021-2022)
Director of the Liver Center and General Medicine 8 at San Raffaele Hospital, Milan, Italy. (2021-2022)
Speaker(s)
Alejandro Forner, MD
Specialist in Hepatology, BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Topic: Epidemiology and Natural History of CCA
Topic: Epidemiology and Natural History of CCA
Juan W. Valle, MB ChB, MSc, FRCP
Professor of Medical Oncology in the University of Manchester (Division of Cancer Sciences, Faculty of Biology, Medicine and Health), Manchester, UK;
Past chair of the UK National Cancer Research Institute (NCRI) neuroendocrine subgroup.
Topic: Evolving Landscape of Systemic Therapy of CCA
Past chair of the UK National Cancer Research Institute (NCRI) neuroendocrine subgroup.
Topic: Evolving Landscape of Systemic Therapy of CCA
Chiara Braconi, MD, PhD
Lord Kelvin Adam Smith Reader, Institute of Cancer Sciences, The University of Glasgow, Glasgow, UK;
Consultant Medical Oncologist at the Beatson West of Scotland Cancer Centre.
Topic: Therapeutic Implications of the Molecular Classification in CCA
Consultant Medical Oncologist at the Beatson West of Scotland Cancer Centre.
Topic: Therapeutic Implications of the Molecular Classification in CCA
Vincenzo Cardinale, MD, PhD
Researcher, Medical Doctor, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
Topic: Professional Societies Recommendations for Treatment of CCA
Topic: Professional Societies Recommendations for Treatment of CCA
Programme
Programme
- Time (Milan, GMT+2)
- Speakers
- Topics
- 13:00 - 13:05
- Chair (Massimo Colombo) Moderator (Giuliano Ramadori)
- Welcome Remarks
- 13:05 - 13:25
- Alejandro Forner
- Epidemiology and Natural History of CCA
- 13:25 - 13:45
- Chiara Braconi
- Therapeutic Implications of the Molecular Classification in CCA
- 13:45 - 14:05
- /
- Discussion Part 1
- 14:05 - 14:10
- Moderator (Giuliano Ramadori)
- Introduction for the Journal
- 14:10 - 14:30
- Juan W. Valle
- Evolving Landscape of Systemic Therapy of CCA
- 14:30 - 14:50
- Vincenzo Cardinale
- Professional Societies Recommendations for Treatment of CCA
- 14:50 - 15:10
- /
- Discussion Part 2
- 15:10 - 15:15
- Chair (Massimo Colombo) Moderator (Giuliano Ramadori)
- Concluding Remarks
Moments
Presentation
Alejandro Forner, Specialist in Hepatology, BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Topic: Epidemiology and Natural History of CCA
NaN
Chiara Braconi, Lord Kelvin Adam Smith Reader, Institute of Cancer Sciences, The University of Glasgow, Glasgow, UK;
Consultant Medical Oncologist at the Beatson West of Scotland Cancer Centre.
Topic: Therapeutic Implications of the Molecular Classification of Biliary Cancers
NaN
Discussion part 1 of the webinar "Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon"
NaN
Juan W. Valle, Professor of Medical Oncology in the University of Manchester (Division of Cancer Sciences, Faculty of Biology, Medicine and Health), Manchester, UK; Past chair of the UK National Cancer Research Institute (NCRI) neuroendocrine subgroup.
Topic: Evolving Landscape of Systemic Therapy of CCA
NaN
Vincenzo Cardinale, Researcher, Medical Doctor, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
Topic: Professional Societies Recommendations for Treatment of CCA
NaN
Discussion part 2 of the webinar "Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon"
NaN
